Purdue and Evonik launch strategic partnership in pharmaceutical manufacturing
A new partnership between Purdue and Evonik, a pharmaceutical manufacturer, plans to support sponsored research, product and technology development, manufacturing collaboration, and workforce and economic development. (Photo provided by Krock Photography LLC)
WEST LAFAYETTE, Ind. — Purdue University is launching a new industry partnership with Evonik, one of the world’s leading specialty chemicals companies. The partnership agreement lays the groundwork for sponsored research, product and technology development, manufacturing collaboration, and workforce and economic development.
The agreement follows Evonik’s investment of $100 million to update its drug substance manufacturing site in Lafayette. Near Purdue’s West Lafayette campus, the site is home to one of the world’s largest facilities for the production of active pharmaceutical ingredients and is a major employer in the Greater Lafayette region.
According to Eric Woods, executive director of Purdue’s One Health initiative in the Office of Industry Partnerships, this new agreement will support Purdue’s educational mission by connecting students with an industry leader in pharmaceutical manufacturing and providing resources for research and industry collaboration.
“Partnerships like this create value for both Purdue and industry by bringing together complementary strengths and expertise,” Woods said.
“Evonik brings deep experience in pharmaceutical manufacturing and a strong presence in our community, while Purdue brings world-class research, education and talent. Together, we can create new opportunities for collaboration, give students meaningful exposure to industry, and help advance innovations that strengthen the pharmaceutical workforce and economy in Indiana,” he said.
This partnership agreement comes at an opportune time, as the pharmaceutical industry is experiencing rapid growth globally and in Indiana, where over 70,000 workers are employed in pharmaceutical fields. Purdue’s College of Pharmacy is a world leader in pharmaceutical research, drug development and drug discovery and is home to innovative programs such as the new online Master of Science in radiopharmaceutical manufacturing.
This new partnership agreement seeks to advance Evonik’s commercial manufacturing and technological capabilities by connecting the company with one of the country’s leading research universities, said Michelle Brown, production planning manager at Evonik.
“Evonik has had a long-standing relationship with Purdue University, and the partnership has created numerous opportunities for collaboration, innovation and talent development,” she said. “We’ve intentionally connected Purdue’s academic expertise with Evonik’s industry knowledge to build a foundation for transformation and development within our workforce.”
Todd Wetli, vice president and site manager of Evonik’s Tippecanoe Laboratories, said the partnership is built on shared goals, including supporting local industry and communities.
“This agreement reflects our shared commitment to advancing innovation through collaboration. By combining Purdue’s world-class research capabilities with our industry expertise, we can accelerate the development of solutions that create value for our customers, our communities and the industries we serve,” he said.
The partnership agreement was finalized at a signing ceremony Aug. 5 on Purdue’s campus. The ceremony was attended by leadership from Purdue University and Purdue Research Foundation, as well as representatives from Evonik’s Lafayette site.
About Purdue University’s Office of Industry Partnerships
Purdue’s Office of Industry Partnerships (OIP) builds strategic collaborations between Purdue University and industry partners to develop talent, drive innovation and support economic growth. OIP acts as a central resource, providing comprehensive internal support to all university units and acting as a concierge for external partners.
About Purdue University
Purdue University is a research institution ranked among the top 10 public universities in the United States. More than 111,000 students study at Purdue across multiple campuses, including more than 57,000 at our main campus locations in West Lafayette and Indianapolis. As a land-grant university committed to affordability and accessibility, Purdue’s main campus has frozen tuition 14 years in a row, enabling more students than ever to graduate debt-free.
Media contact: Trevor Peters, peter237@purdue.edu